Umberto Pensato on Cancer and Stroke
Umberto Pensato, Assistant Professor of Neurology at the Humanitas University, Research Collaborator at the University of Calgary, shared on LinkedIn:
”Stroke in patients with cancer is common (1 every 7 patients), yet it is becoming extremely challenging to understand patient prognosis and goal-of-care, especially in the time-pressured environment of acute stroke care, resulting in missed/delayed acute treatment (not really in keeping with “Time is Brain”).
This is a call for oncologists, please provide upfront: (i)life expectancy (> or < 6 months?), (ii) goal-of-care (resuscitate, medical or comfort?), and (iii) intent of oncologist treatment (curative or palliative). Help us treat these patients better and faster
Take a look at our viewpoint in JAMA Oncology, Ronda Lun, Jeffrey Q Cao, and Andrew Demchuk, Humanitas University, University of Calgary”
Read the full article here.
Article: Stroke in Patients With Cancer—Time Is Brain
Authors: Ronda Lun, Jeffrey Q Cao, Andrew Demchuk, Umberto Pensato
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy
-
Jun 25, 2026, 15:23Jonas Kingo: ISTH 2026 in Paris Brings the Global Hemostasis Community Together
-
Jun 25, 2026, 15:21Balancing Therapeutic Progress and Emergency Preparedness in Hemophilia – CRH French Reference Center for Hemophilia Lyon
-
Jun 25, 2026, 15:06Ifeanyichukwu Ifechidere: What If One of the Biggest Myth Fact About APS is Hidden in its Name?
-
Jun 25, 2026, 15:05Gopal Patidar: Advancing Haemovigilance and Global Collaboration at ISBT 2026
-
Jun 25, 2026, 14:52Violeta Jardin: Measuring Antifibrinolytic Effect to Improve Tranexamic Acid Safety